Medicinal chemistry section.

The Medicinal Chemistry Section is part of the Experimental Therapeutics Interdisciplinary Programme that is dedicated to early Drug Discovery activities in the oncology field. Our mission is to discover and to develop new anticancer agents based on novel hypotheses and targets generated by CNIO’s Basic Research Groups, and to do so in close collaboration with these groups. Medicinal chemists are responsible for the design, the preparation and the optimisation of compounds for biological evaluation, as well as for the generation of Structure Activity Relationships ( SARs ) and the development of novel lead compounds with in vivo activity in appropriate animal models.